Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT05288400

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Servier (from the registry)
Registry
  • NCT NCT05288400
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05288400. Randomized; no masking; primary purpose treatment. Start 2018-05-14 (actual); primary completion 2018-12-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.
Condition
Essential Hypertension
Intervention (Combination product)
Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg
Intervention (Drug)
Norvasc 5mg tablet
Intervention (Drug)
Concor 5mg tablet
Intervention (Drug)
Coversyl 5mg tablet
Lead sponsor
Servier (class: industry)

Record details

Record id
cardio:ct-nct05288400
Content hash
80de776313f02b7d0d7cc01619fa7a04781ae8aeee5e43b15a9471a732e5e9bc